| 摘要 |
<p>The present invention provides methods and compositions for treating HMFG-and CEA-associated tumors using an anti-idiotype antibody for HMFG, such as antibody 11D10, in conjunction with an anti-idiotype antibody for CEA, such as antibody 3H1.</p> |
